Grasp production after the festival, the first lesson is about safety.
Release time:
2023-02-17
News from our newspaper In order to help employees "to receive " after the holiday and further improve their awareness of production safety, the government departments and enterprises where the company's subordinate enterprises are located have successively carried out post-holiday production safety inspections and held special meetings on production safety to further implement the work of production safety in the new year.
Recently, Daye Emergency Management Bureau set up a supervision and inspection team to Daye Peak Cement Company to carry out post-holiday safety production work. The supervision and inspection team went deep into the production workshop, warehouse, project construction site and other production lines, focusing on checking whether the enterprise has formulated and strictly implemented the work plan for resuming work and production, whether the safety meeting, safety training, safety commitment and safety warning are really in place, the maintenance of safety protection devices and production equipment after the festival, and the work of key parts such as power distribution room, central control room, limited space and special equipment use places. The supervision and inspection team stressed that enterprises should resolutely overcome the paralysis and lax thinking brought about by "holiday syndrome " , carry out post-holiday "heart-to-heart " education in a timely manner, fully grasp the ideological trends of employees, do a good job in pre-job safety education and training, and carry out technical disclosure on post safety risks and operation specifications. It is necessary to strictly implement all safety precautions for resuming work and production, strengthen equipment commissioning management and safety risk investigation and remediation to ensure production safety. (Hu Ning Wu Xinqiong)
January 29 morning, Anhui East to the Economic Development Zone Emergency Management Bureau went to Anhui Jianfeng Beika Pharmaceutical Co., Ltd. to conduct a safety inspection on the resumption of work and production after the holiday. The inspectors talked face-to-face with the main person in charge of Anhui Jianfeng North Carolina and the person in charge of safety to understand the resumption of work and production safety of the enterprise, and repeatedly reminded that safety education and training for all employees must be strengthened during the resumption of work and production to improve the safety awareness of employees. During the inspection, the inspectors carefully checked the relevant resumption of work and production data, and inspected the workshop site to provide protection for the safe, smooth and orderly resumption of work and production in Anhui Jianfeng North Card. (Song Danlin)
1 29 , the raw material workshop of Jianfeng Pharmaceutical Production Department organized safety training, process training and full-staff safety production responsibility training after the holiday, and carried out the first on-site disposal drill for hazardous chemical leakage in the New Year. (lu xianhui)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31